Patent details
LUC00036
Product Name:
Trifluridine combinée au tipiracil ou un sel de tipiracil tel que l'hydrochlorure de tipiracil
Basic Information
- Publication number:
- LUC00036
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP067122929
- Legal Status:
- Active
- Application number:
- LUC00036
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/16/1096
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 27/04/2016
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 29/09/2017
- First Marketing Authorization date:
- 27/04/2016
- Grant date:
- 01/12/2017
- Activation date:
- Publication date:
- 02/10/2017
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 25/01/2031
- SPC Extension Expiration:
- 25/01/2031
- Rejection date:
- Withdrawal date:
Owner
- From:
- 29/09/2017
-
-
- Name:
- Taiho Pharmaceutical Co., Ltd.
- Address:
- 1-27 Kandanishiki-cho, Chiyoda-ku
Tokyo 101-8444, Japan (JP)
Agent
- Name:
- ARONOVA S.A.
- From:
- 29/09/2017
- Address:
- PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2017/07
- Publication date:
- 11/12/2017
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2018/02
- Publication date:
- 15/01/2018
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 01/02/2027
- Annual Fee Number:
- 22
- Annual Fee Amount:
- 420 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 16/01/2026
- Last Annual Fee Paid Number:
- 21
- Last Annual Fee Paid Amount:
- 410 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM